Back to search
Central Line Bloodstream Infections
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line Bloodstream Infections trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line Bloodstream Infections trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I)…
This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult partici…
This study is a post-marketing approval requirement to assess the safety and time to Catheter-related Bloodstream Infections (CRBSI) of DefenCath in pediatric p…
Central line-associated bloodstream infections (CLABSIs) are the most common healthcare-associated infection in children and are associated with morbidity and m…
In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications,…
In recent years, with the rapid advancement of medical technology and the rapid development of critical care medicine, the use of various central venous cathete…
The number of elderly hemodialysis patients is growing. Vascular access complications are a major determinant of the quality of life and health care costs for t…
The EAP for DefenCath is designed to provide access to a broader population of adult and pediatric patients using catheters for various serious medical conditio…